Litcius/Paper detail

Duration of immunotherapy in dMMR/MSI-H metastatic colorectal cancer patients

Ofer Margalit, Amos Stemmer, William J. Chapin, Einat Shacham‐Shmueli, Scott Kopetz, Thierry André, Michael J. Overman, Filippo Pietrantonio, Ben Boursi

2024European Journal of Cancer20 citationsDOI

Topics & Concepts

MedicineColorectal cancerOncologyImmunotherapyInternal medicineCancerCancer Immunotherapy and BiomarkersGenetic factors in colorectal cancerColorectal Cancer Treatments and Studies
Duration of immunotherapy in dMMR/MSI-H metastatic colorectal cancer patients | Litcius